These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 19584105)
1. Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycin. Nathwani D J Antimicrob Chemother; 2009 Sep; 64(3):447-53. PubMed ID: 19584105 [TBL] [Abstract][Full Text] [Related]
2. Comment on: Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycin. Adriaenssens N; Goossens H; Coenen S; J Antimicrob Chemother; 2009 Dec; 64(6):1347. PubMed ID: 19841030 [No Abstract] [Full Text] [Related]
16. [Daptomycin in home hospitalization]. González Ramallo VJ Med Clin (Barc); 2010 Dec; 135 Suppl 3():48-54. PubMed ID: 21477704 [TBL] [Abstract][Full Text] [Related]
17. A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective. Yong C; Fisher DA; Sklar GE; Li SC Int J Antimicrob Agents; 2009 Jan; 33(1):46-51. PubMed ID: 18823759 [TBL] [Abstract][Full Text] [Related]
18. A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria. Katz DE; Lindfield KC; Steenbergen JN; Benziger DP; Blackerby KJ; Knapp AG; Martone WJ Int J Clin Pract; 2008 Sep; 62(9):1455-64. PubMed ID: 18662172 [TBL] [Abstract][Full Text] [Related]
19. Impact of a multidisciplinary team review of potential outpatient parenteral antimicrobial therapy prior to discharge from an academic medical center. Heintz BH; Halilovic J; Christensen CL Ann Pharmacother; 2011 Nov; 45(11):1329-37. PubMed ID: 21990938 [TBL] [Abstract][Full Text] [Related]